| ligand | solubility (pH7, mmol/l)/logP |
AC-/PLC- mediated Ca2+ response, EC50, μM |
time of peak, s, AC-/PLC- dependent Ca2+ response |
time to rise 10% to 90%, s, AC-/PLC- dependent Ca2+ response |
decay time 90% to 10%, s, AC-/PLC- dependent Ca2+ response |
| eugenol | 11/2.4 | 55±38/53.3±11 | 90.5±4.4/15.4±0.4 | 39.4±2.2/7.6±0.2 | 128.2±4.9/52.6±1.1 |
| methyl eugenol | 4.3/2.7 | 177±11/165.3±7.2 | 92±3/19.8±1.2 | 41.6±2.2/5.4±0.6 | 101.2±6/39.8±2.3 |
| vanillin | 28/1.2 | 162±68/ 218.1 ±27.1 | 85.3±2.9/18.6±0.9 | 31.4±1.3/8.3±0.5 | 101.7±2.6/48±2.9 |
| ethyl vanillin | 11/1.7 | 2165±131/1487±716 | 91.6±5.8/22.6±1.5 | 36.9±3.3/9.5±0.8 | 115.7±10.8/52.3±4.8 |
| acetyl eugenol | 1.4/2.7 | 373±49/348±25 | 90.8±3.4/19.6±0.9 | 27.6±1.7/7.7±0.4 | 125.5±5.1/44±1 |
| orivone | 2.4/3.1 | 4600±535/4370±471 | 94.9±5.3/29.8±2.3 | 36.4±2.6/8±1 | 101±5/47.6±4.1 |
| methyl isoeugenol | 3.6/3.05 | non agonist, antagonist |
|||
| isosafrole | 0.6/3.9 | non agonist, antagonist (*) |
|||
| isoeugenol | 7.3/3.08 | 286±40.3/35.4±4.8 | 95.3±4.8/37.1±3.5 | 36.7±2.7/14.8±1.6 | 104±4.8/54.5±2.6 |
| 4-propylguaiacol | 6/2.9 | 205±15/174±88 | 95.8±3.9/23±1 | 46±3/5.7±0.4 | 128.2±8.5/36.3±2.8 |
| 4-ethylguaiacol | 14/2.4 | 1057±861/66±44 | 79.3±2.3/22.1±0.8 | 31.5±1.7/6.1±0.3 | 101.6±6.7/71.3±4.9 |
| 4-vinylguaiacol | 15/2.6 | 211±226/56.2±4.9 | 85.1±4.3/21.5±0.8 | 34.2±2.1/5.6±0.4 | 113±102/49.7±4.2 |
| mousse cristal | 10/2.8 | 551±22/253±81 | 107.3±2.4/30.7±1.4 | 32.6±1.6/14±1 | 117.6±5.3/74±4 |
| nootkatone | 0.24/3.8 | no effects | |||
| raspberryketone | 31/1.3 | no effects | |||
| 4-isopropylphenol | 15/3 | no effects | |||
| 4-tert-butylphenol | 6.3/3.4 | no effects |